Abstract
During the last years significant efforts have been made to discover compounds with inhibitory activity of quorum-sensing systems, which could represent an anti-pathogenic strategy, since they will inhibit the coordinated expression of virulence determinants, without interfering with bacterial growth, being less likely to generate resistance. The present study is reviewing the main types of quorum sensing inhibitors known to date, that manifest the potential to be used as anti-virulence drugs for the treatment of infections with multidrug resistant P. aeruginosa strains, and describes a new strategy of virulence attenuation based on organic acids produced by probiotic strains, which have been proved to influence in sub-inhibitory (sI) grown concentrations the QS genes expression in P. aeruginosa multidrug resistant strains, proving that the organic acids secreted by probiotics could act as quorum sensing inhibitors.
Keywords: Anti-pathogenic strategy, Multidrug resistance, Quorum-sensing inhibitors, P. aeruginosa, probiotics
Current Organic Chemistry
Title:Anti-pathogenic Strategies for Fighting Pseudomonas aeruginosa Infections- probiotic Soluble Compounds as Inhibitors of Quorum Sensing Genes Expression
Volume: 17 Issue: 2
Author(s): Ani Ioana Cotar, Crina Saviuc, Roxana Andreea Nita, Eugenia Bezirtzoglou, Veronica Lazar and Mariana Carmen Chifiriuc
Affiliation:
Keywords: Anti-pathogenic strategy, Multidrug resistance, Quorum-sensing inhibitors, P. aeruginosa, probiotics
Abstract: During the last years significant efforts have been made to discover compounds with inhibitory activity of quorum-sensing systems, which could represent an anti-pathogenic strategy, since they will inhibit the coordinated expression of virulence determinants, without interfering with bacterial growth, being less likely to generate resistance. The present study is reviewing the main types of quorum sensing inhibitors known to date, that manifest the potential to be used as anti-virulence drugs for the treatment of infections with multidrug resistant P. aeruginosa strains, and describes a new strategy of virulence attenuation based on organic acids produced by probiotic strains, which have been proved to influence in sub-inhibitory (sI) grown concentrations the QS genes expression in P. aeruginosa multidrug resistant strains, proving that the organic acids secreted by probiotics could act as quorum sensing inhibitors.
Export Options
About this article
Cite this article as:
Ioana Cotar Ani, Saviuc Crina, Andreea Nita Roxana, Bezirtzoglou Eugenia, Lazar Veronica and Carmen Chifiriuc Mariana, Anti-pathogenic Strategies for Fighting Pseudomonas aeruginosa Infections- probiotic Soluble Compounds as Inhibitors of Quorum Sensing Genes Expression, Current Organic Chemistry 2013; 17 (2) . https://dx.doi.org/10.2174/1385272811317020012
DOI https://dx.doi.org/10.2174/1385272811317020012 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Progress on Multi-Modality Molecular Imaging
Current Medical Imaging Pharmacological Treatment in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Treatment of Allergic Asthma by Targeting Transcription Factors Using Nucleic-Acid Based Technologies
Current Pharmaceutical Design Microparticles: A Pivotal Nexus in Vascular Homeostasis and Disease
Current Clinical Pharmacology Cigarette Smoke-Induced Proteostasis Imbalance in Obstructive Lung Diseases
Current Molecular Medicine Current Understanding of Dietary Polyphenols and their Role in Health and Disease
Current Nutrition & Food Science Goal Directed Fluid Therapy
Current Pharmaceutical Design Trick-or-Treat: Dietary Lipids and Host Resistance to Infectious Disease
Mini-Reviews in Medicinal Chemistry Nursing Assessment, Education, and Care of Extremely Premature Neonates with Patent Ductus Arteriosus
Current Pediatric Reviews Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Transcatheter Aortic Valve Technology: Current State
Recent Patents on Biomedical Engineering (Discontinued) Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization
Current Pharmaceutical Design Contemporary Management of Hypertension - How to Optimize Therapy
Cardiovascular & Hematological Disorders-Drug Targets The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Adenosine, Ketogenic Diet and Epilepsy: The Emerging Therapeutic Relationship Between Metabolism and Brain Activity
Current Neuropharmacology Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates
Recent Patents on Biotechnology The Application of X-ray, NMR, and Molecular Modeling in the Design of MMP Inhibitors
Current Topics in Medicinal Chemistry Graphical Abstracts
Inflammation & Allergy - Drug Targets (Discontinued) New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design